norethindrone has been researched along with dinoprostone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Boyd, ME | 1 |
Crook, D; Ellerington, MC; Marsh, MS; Stevenson, JC; Whitcroft, SI; Whitehead, MI | 1 |
1 trial(s) available for norethindrone and dinoprostone
Article | Year |
---|---|
Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
Topics: Administration, Cutaneous; Administration, Oral; Alprostadil; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dinoprostone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Postmenopause; Time Factors; Triglycerides | 1994 |
3 other study(ies) available for norethindrone and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Dysfunctional uterine bleeding.
Topics: Adult; Contraceptives, Oral; Cyclooxygenase Inhibitors; Dilatation and Curettage; Dinoprost; Dinoprostone; Emergencies; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Prostaglandins E; Prostaglandins F | 1986 |